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Introduction
Intensive care unit-acquired weakness (ICUAW) is a ser-
ious complication associated with loss of muscle mass and
strength, metabolic disorders, organ failure, failure to
wean, and increased mortality. ICUAW is diagnosed via
MRC scores, and electrophysiological examinations (EP)
can detect muscle excitability disorders associated with
ICUAW (1). While uncontrolled hyperglycemia and/or
insulin resistance has been linked to ICUAW (2), glucose
variability, promoted by Krinsley et al as a crucial para-
meter independently linked to ICU mortality (3), has thus
far been neglected in ICUAW studies. There is a lack of
standardization in the assessment of glucose variability,
and not all methods associate with mortality.
Objective
The aim was to assess the relationship between blood
glucose variability and the incidence of ICUAW. Such a
relationship could identify variability as an early ICUAW
risk factor. As this was the first attempt to find such corre-
lation, differing metrics were examined.
Methods
This study examined data from 3 previous studies, includ-
ing 101 ICU patients from Charité Medical University in
Berlin, with a Sequential Organ Failure (SOFA) score ≥ 9
within the first 5 days of admission, mechanical ventila-
tion, available consent, and specific ICUAW diagnostics
via MRC and/or EP. Exclusion criteria included diabetes
mellitus, BMI > 35, and preexisting neuromuscular
disorders. We analyzed 4 daily glucose readings via blood
gas analyzer at regular intervals, and computed common
variability measurements suitable to our data. (Ethics Vote
EA1/017/11)
Results
For each patient, we calculated the standard deviation
(SD), mean absolute glucose (MAG), mean amplitude of
glycemic excursions (MAGE), and lability index (LI).
These values were analyzed against MRC scores and EP
diagnoses. Measurements were analyzed for the first
7 days, as well as until the time of the first MRC score,
when the patient was deemed sufficiently awake for the
first time. No significant correlation and/ or group differ-
ences could be found (Figure 1 and 2).
Conclusions
None of the metrics tested identified a correlation between
glycemic variability and ICUAW. Further studies using
continuous measurement systems would allow additional
metrics to be tested.
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Figure1 p-values comparing glucose variability of ICUAW and
non-ICUAW patients, grouped by diagnostic method and
evaluation perod. Electrophysiological results indicate
nonexcitable muscle membrane, but not necessarily ICUAW.
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Figure 2 Patient results for standard deviation, grouped by MRC score (mean <4 = ICUAW) and electrophysiological results
(Compound Muscle Action Potential after direct muscle stimulation (dmCMAP < 3mV)) as predictor for ICUAW.
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